Editorial Commentary
Cost-effectiveness of cancer screening and overall survival benefit
Translational Cancer Research
2026;
15
(3)
:137
.
(31 March 2026)
Hepatocellular carcinoma’s inflammatory secret: ferroptosis as the key
Translational Cancer Research
2026;
15
(3)
:138
.
(31 March 2026)
Immune profiling in residual disease: refining risk stratification after neoadjuvant therapy in HER2-positive breast cancer
Translational Cancer Research
2026;
15
(3)
:139
.
(31 March 2026)
UV1 plus pembrolizumab in recurrent and metastatic head and neck squamous cell carcinoma: safe, immunogenic, but lacking efficacy
Translational Cancer Research
2026;
15
(3)
:140
.
(31 March 2026)
Original Article
Plasma-derived exosomal miRNA as a promising diagnostic biomarker for detection of diffuse large B-cell lymphoma
Translational Cancer Research
2026;
15
(3)
:141
.
(31 March 2026)
High expression of TMEM119 predicts a poor prognosis in gastric cancer
Translational Cancer Research
2026;
15
(3)
:142
.
(31 March 2026)
Systematic evaluation and meta-analysis of the diagnostic accuracy of ultrasound contrast in predicting the efficacy of systemic therapy for advanced hepatocellular carcinoma
Translational Cancer Research
2026;
15
(3)
:143
.
(31 March 2026)
Development and validation of machine learning models for predicting synchronous lung metastasis in United States colorectal cancer patients: a SEER database analysis
Translational Cancer Research
2026;
15
(3)
:144
.
(31 March 2026)
Prognostic alternative splicing signatures in esophageal cancer reveal SF3A3 as a key oncogenic splicing factor
Translational Cancer Research
2026;
15
(3)
:145
.
(31 March 2026)
Targeting chitinase-3-like protein 2 (CHI3L2) suppresses cell proliferation and migration in glioblastoma
Translational Cancer Research
2026;
15
(3)
:146
.
(31 March 2026)
Molecular classification and construction of prognostic risk model via machine learning based on metabolic-related genes in hepatocellular carcinoma
Translational Cancer Research
2026;
15
(3)
:147
.
(31 March 2026)
Targeting LRPPRC lactylation disrupts metabolic-immune crosstalk and restores antitumor immunity in hepatocellular carcinoma
Translational Cancer Research
2026;
15
(3)
:148
.
(31 March 2026)
Low LAMA2 expression may affect drug resistance and prognosis in ovarian cancer via positive LGR5 coexpression
Translational Cancer Research
2026;
15
(3)
:149
.
(31 March 2026)
Co-assembled structures of Fe3O4 nanoparticles for therapy of cervical cancer by inducing apoptosis and autophagy
Translational Cancer Research
2026;
15
(3)
:150
.
(31 March 2026)
Prognostic modeling and validation of middle ear malignancy outcomes on the basis of SEER population data
Translational Cancer Research
2026;
15
(3)
:151
.
(31 March 2026)
Association of CAB39L gene methylation in peripheral blood leukocytes with the risk, chemotherapy efficacy and prognosis of gastric cancer and construction of risk prediction model
Translational Cancer Research
2026;
15
(3)
:152
.
(31 March 2026)
Identification and validation of a sphingolipid metabolism-related prognostic signature for predicting prognosis and immune microenvironment-related characteristics in ovarian cancer
Translational Cancer Research
2026;
15
(3)
:153
.
(31 March 2026)
Survival outcomes by molecular subtypes based on receptor status in medullary breast carcinoma: a SEER database analysis
Translational Cancer Research
2026;
15
(3)
:154
.
(31 March 2026)
The construction and validation of a nomogram for lung metastasis of intrahepatic cholangiocarcinoma: a study based on the SEER database
Translational Cancer Research
2026;
15
(3)
:155
.
(31 March 2026)
Analysis of prognostic factors in ovarian clear cell carcinoma: a retrospective cohort study
Translational Cancer Research
2026;
15
(3)
:156
.
(31 March 2026)
Construction and validation of risk prediction model for glioblastoma associated with cancer stem cells and disulfidptosis
Translational Cancer Research
2026;
15
(3)
:157
.
(31 March 2026)
Prognostic stratification in non-small cell lung cancer using a TIDE-informed transcriptomic signature: model development and validation
Translational Cancer Research
2026;
15
(3)
:158
.
(31 March 2026)
Cinobufotalin reduces glioblastoma resistance to temozolomide by inhibiting the CCL5-mediated PI3K/Akt/mTOR signaling pathway
Translational Cancer Research
2026;
15
(3)
:159
.
(31 March 2026)
Tumor mutation burden predicts aggressiveness and prognosis of gastrointestinal stromal tumor
Translational Cancer Research
2026;
15
(3)
:160
.
(31 March 2026)
Construction of competing-risk nomograms and identification of optimal candidates for aggressive therapy in gastric cancer with peritoneal metastasis: a population-based study
Translational Cancer Research
2026;
15
(3)
:161
.
(31 March 2026)
m6A modified circPTK2 mediates TNBC chemotherapy resistance
Translational Cancer Research
2026;
15
(3)
:162
.
(31 March 2026)
Gene expression profile, and role of baicalein in the inhibition of thyroid cancer
Translational Cancer Research
2026;
15
(3)
:163
.
(31 March 2026)
KCNK9 could be a prognostic biomarker in uterine corpus endometrial carcinoma
Translational Cancer Research
2026;
15
(3)
:164
.
(31 March 2026)
Study on the inhibition of thyroid undifferentiated carcinoma metastasis by nanoparticles loaded with EZH2 inhibitor
Translational Cancer Research
2026;
15
(3)
:165
.
(31 March 2026)
A pretreatment 18F-FDG PET/CT-based nomogram for the differential diagnosis of primary gastric cancer and primary gastric diffuse large B-cell lymphoma
Translational Cancer Research
2026;
15
(3)
:166
.
(31 March 2026)
Prognostic value of systemic inflammation indices in patients with metastatic colorectal cancer treated with TAS-102: a single-center retrospective real-world study
Translational Cancer Research
2026;
15
(3)
:167
.
(31 March 2026)
A prediction model of gastric cancer based on M2-like tumor-associated macrophage infiltration verified by immunohistochemistry
Translational Cancer Research
2026;
15
(3)
:168
.
(31 March 2026)
Integrative analysis reveals the role of SUMOylation-related patterns in shaping the tumor microenvironment and predicting treatment sensitivity of colorectal cancer
Translational Cancer Research
2026;
15
(3)
:169
.
(31 March 2026)
Stigmasterol reverses rituximab resistance in diffuse large B-cell lymphoma via the MAPK1 signaling pathway
Translational Cancer Research
2026;
15
(3)
:170
.
(31 March 2026)
LAPTM5-dependent lipophagy enhances ferroptosis sensitivity in glioma cells
Translational Cancer Research
2026;
15
(3)
:171
.
(31 March 2026)
A ferroptosis-related competing endogenous RNA network: HOX transcript antisense intergenic RNA/miR-129-5p/brain and acute leukemia, cytoplasmic axis contributes to the malignant progression of esophageal squamous cell carcinoma
Translational Cancer Research
2026;
15
(3)
:172
.
(31 March 2026)
Integrated bulk RNA-seq and scRNA-seq identification of a novel “PET-SPI1-MYL9” transcriptional axis in lung adenocarcinoma driven by polyethylene terephthalate exposure
Translational Cancer Research
2026;
15
(3)
:173
.
(31 March 2026)
RNAscope-based HER2 mRNA detection shows high concordance with fluorescence in situ hybridization in invasive breast carcinoma: a retrospective study
Translational Cancer Research
2026;
15
(3)
:174
.
(31 March 2026)
Quetiapine inhibits the oxidative phosphorylation in head and neck squamous cell carcinoma through suppressing NAT10-mediated ac4C modification
Translational Cancer Research
2026;
15
(3)
:175
.
(31 March 2026)
Clinical characteristics, prognosis, and nomograms for lung invasive mucinous adenocarcinoma with distant metastasis: a population-based study
Translational Cancer Research
2026;
15
(3)
:176
.
(31 March 2026)
Clinical prognostic prediction of MMP13 expression in head and neck squamous cell carcinoma using contrast-enhanced computed tomography radiomics: a model development and validation study
Translational Cancer Research
2026;
15
(3)
:177
.
(31 March 2026)
MicroRNA-663a upregulation upon ARID1A depletion promotes the growth and migration of esophageal cancer cells by targeting FKBP8
Translational Cancer Research
2026;
15
(3)
:178
.
(31 March 2026)
CA9-related ferroptosis is a potential therapeutic target of kaempferol anti-oral squamous cell carcinoma
Translational Cancer Research
2026;
15
(3)
:179
.
(31 March 2026)
Pan-cancer analysis reveals FOLH1 as a prognostic biomarker and immune modulator in human tumors
Translational Cancer Research
2026;
15
(3)
:180
.
(31 March 2026)
Obovatol induces apoptosis in breast cancer by downregulating the PI3K/Akt pathway
Translational Cancer Research
2026;
15
(3)
:181
.
(31 March 2026)
Identification of papillary thyroid carcinoma-associated epithelial cell subpopulations and diagnostic biomarkers: integrating machine learning with single-cell analysis
Translational Cancer Research
2026;
15
(3)
:182
.
(31 March 2026)
Molecular mechanisms of inhalable iron-containing particles driving lung carcinogenesis through the LCN2 signaling axis revealed by transcriptomic analysis
Translational Cancer Research
2026;
15
(3)
:183
.
(31 March 2026)
Prognostic value of DNA methylation in head and neck cancer: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(3)
:184
.
(31 March 2026)
ZNF460 inhibits HMGCL and promotes PI3K pathway in colon cancer
Translational Cancer Research
2026;
15
(3)
:185
.
(31 March 2026)
Pre-clinical anti-tumor activity and preliminary safety of METTL3 inhibitors STM2457 and UZH1a in neuroblastoma
Translational Cancer Research
2026;
15
(3)
:186
.
(31 March 2026)
Individualized treatment and key prognostic biomarkers based on folate metabolism in patients with pancreatic cancer
Translational Cancer Research
2026;
15
(3)
:187
.
(31 March 2026)
Impact of prior cancer history on survival in patients with adenocarcinoma of esophagogastric junction: a retrospective cohort study using SEER database
Translational Cancer Research
2026;
15
(3)
:188
.
(31 March 2026)
Experimental study of ultrasound combined with microbubbles augmenting the sonodynamic therapy of 5-aminolevulinic acid in glioma cells
Translational Cancer Research
2026;
15
(3)
:189
.
(31 March 2026)
Corylin inhibits liver cancer cell growth through the endogenous apoptosis and mitophagy
Translational Cancer Research
2026;
15
(3)
:190
.
(31 March 2026)
Prognostic role of lymph node-related indices and development/internal validation of a novel nomogram in colorectal cancer patients with synchronous lung metastases: a study based on the SEER database
Translational Cancer Research
2026;
15
(3)
:191
.
(31 March 2026)
Extracellular vesicle-derived lncRNA-NEAT1 serves as potential biomarker for the early diagnosis of hepatocellular carcinoma
Translational Cancer Research
2026;
15
(3)
:192
.
(31 March 2026)
GPR176 represses mitophagy to promote the progression of osteosarcoma by facilitating mTORC1 activity via PI3K-AKT pathway
Translational Cancer Research
2026;
15
(3)
:193
.
(31 March 2026)
Development and feasibility assessment of an automated, synthetic CT-guided plan selection system for bladder cancer adaptive radiotherapy: a retrospective pilot study
Translational Cancer Research
2026;
15
(3)
:194
.
(31 March 2026)
Molecular subtyping and prognostic modeling of non-small cell lung cancer based on disulfidptosis-related genes
Translational Cancer Research
2026;
15
(3)
:195
.
(31 March 2026)
Identification of potential hub biomarkers for gastric high-grade intraepithelial neoplasia early diagnosis: evidence from gene expression profiles and pathological characters
Translational Cancer Research
2026;
15
(3)
:196
.
(31 March 2026)
Curcumin inhibits the proliferation of diffuse large B-cell lymphoma by inducing ferroptosis via the ACSL4-SAT1-GPX4 axis
Translational Cancer Research
2026;
15
(3)
:197
.
(31 March 2026)
SERPINH1, a regulatory factor of oligodendroglioma cell invasion and extracellular matrix secretion, as a novel prognostic biomarker and therapeutic target
Translational Cancer Research
2026;
15
(3)
:198
.
(31 March 2026)
Triglyceride-to-glucose index and lymphocyte-to-monocyte ratio enhance prognostic accuracy for colorectal cancer patients: a multicenter machine learning cohort study
Translational Cancer Research
2026;
15
(3)
:199
.
(31 March 2026)
Inhibition of proliferation and metastasis of nasopharyngeal carcinoma by kaempferol via down-regulation of c-Jun
Translational Cancer Research
2026;
15
(3)
:200
.
(31 March 2026)
A retrospective cohort study comparing long-term clinical outcomes between patients with and without neoadjuvant therapy in stage IB–IIB cervical cancer: a propensity score-matched study
Translational Cancer Research
2026;
15
(3)
:201
.
(31 March 2026)
Evaluation of triphenyl phosphate’s pathogenic potential and molecular mechanisms in glioblastoma: an integrated network toxicology investigation employing multiple machine learning approaches
Translational Cancer Research
2026;
15
(3)
:202
.
(31 March 2026)
Establishment and validation of a model for predicting postoperative recurrence of sinonasal tumors based on multimodality MRI parameters
Translational Cancer Research
2026;
15
(3)
:203
.
(31 March 2026)
Development and internal validation of a prognostic nomogram for lung metastasis in locally advanced rectal cancer incorporating molecular markers
Translational Cancer Research
2026;
15
(3)
:204
.
(31 March 2026)
KRT80 promotes colon adenocarcinoma progression via stat3 pathway activation and immune microenvironment remodeling
Translational Cancer Research
2026;
15
(3)
:205
.
(31 March 2026)
IGF2BP3-mediated stabilization of RHOA mRNA promotes osteosarcoma proliferation via Hippo signaling
Translational Cancer Research
2026;
15
(3)
:206
.
(31 March 2026)
Vitamin B3 suppresses RasV12-driven tumor growth in Drosophila via redox regulation, mitochondrial function, and autophagy activation
Translational Cancer Research
2026;
15
(3)
:207
.
(31 March 2026)
Development and validation of a cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response in breast cancer: a retrospective analysis of TCGA data
Translational Cancer Research
2026;
15
(3)
:208
.
(31 March 2026)
Improvement of prognosis among patients with lung adenocarcinoma through precision therapy: analysis based on The Cancer Genome Atlas
Translational Cancer Research
2026;
15
(3)
:209
.
(31 March 2026)
Programmed cell death receptor 1 inhibitors combined with paclitaxel-platinum induction chemotherapy for treating patients with locally advanced nasopharyngeal carcinoma: a real-world retrospective study
Translational Cancer Research
2026;
15
(3)
:210
.
(31 March 2026)
Molecular landscape and biomarker associations of functional NTRK fusions: a real-world retrospective cohort study across solid tumors
Translational Cancer Research
2026;
15
(3)
:211
.
(31 March 2026)
The claudin-18.2-CD3 bispecific antibody IBI389 exerts an antitumor effect on malignant tumors with positive claudin-18.2 expression by promoting T-cell infiltration and remodeling the tumor immune microenvironment
Translational Cancer Research
2026;
15
(3)
:212
.
(31 March 2026)
Review Article
Thymic epithelial tumors: a narrative review of diagnostic and therapeutic advances
Translational Cancer Research
2026;
15
(3)
:213
.
(31 March 2026)
Targeting the gut microbiota-metabolite-immune axis in cancer immunotherapy: mechanistic interplay, therapeutic strategies, and translational applications-a narrative review
Translational Cancer Research
2026;
15
(3)
:214
.
(31 March 2026)
Beyond the lung: recognizing incidental breast lesions on chest computed tomography
Translational Cancer Research
2026;
15
(3)
:215
.
(31 March 2026)
Artificial intelligence applications in adaptive radiotherapy—a narrative review
Translational Cancer Research
2026;
15
(3)
:216
.
(31 March 2026)
New model for remote symptom management and self-care of cancer patients based on digital health platforms: a narrative review
Translational Cancer Research
2026;
15
(3)
:217
.
(31 March 2026)
Translational advances in gastric cancer: integrating biomarkers, novel therapies, and microenvironment remodeling in 2025
Translational Cancer Research
2026;
15
(3)
:218
.
(31 March 2026)
Case Report
Camrelizumab-induced intranasal hemangioma in a patient with hepatocellular carcinoma: a case report
Translational Cancer Research
2026;
15
(3)
:219
.
(31 March 2026)
Short-term response to alectinib and rapid progression in a lung squamous cell carcinoma patient harboring an EML4-ALK fusion: a case report
Translational Cancer Research
2026;
15
(3)
:220
.
(31 March 2026)
Multimodal approach for the comprehensive management of non-small cell lung cancer: a case report
Translational Cancer Research
2026;
15
(3)
:221
.
(31 March 2026)
Letter to the Editor
Unraveling glutamine metabolism in ovarian carcinoma: signaling cross-talk, positron emission tomography utility, and therapeutic boundaries
Translational Cancer Research
2026;
15
(3)
:222
.
(31 March 2026)
Glutamine metabolism in ovarian carcinoma: disentangling tumor aggressiveness from chemoresistance
Translational Cancer Research
2026;
15
(3)
:223
.
(31 March 2026)
Erratum
Erratum: LncRNA CASC9 regulates cell proliferation, apoptosis and cell cycle via sponging miR-145-5p in colon cancer cells
Translational Cancer Research
2026;
15
(3)
:224
.
(31 March 2026)
